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Abstract
Background: Self-management education programs can reduce the complications and mortality in type 2
diabetes. The need to structure these programs for outpatient and community care with a vision for long-term
maintenance has been recognised. In Reunion Island, an area affected by epidemiological and nutritional transition,
diabetes affects 18% of the adult population over 30 years, with major social disparities, poor glycaemic control and
frequent cardiovascular complications.
Methods/Design: ERMIES is a randomised controlled trial designed to test the efficacy of a long-term (2 years)
structured group self management educational intervention in improving blood glucose in non-recent, insufficiently
controlled diabetes. After an initial structured educational cycle carried out blind for the intervention arm, patients
will be randomised in two parallel group arms of 120 subjects: structured on-going group with educational
intervention maintained over two years, versus only initial education. Education sessions are organised through a
regional diabetes management network, and performed by trained registered nurses at close quarters. The
educational approach is theoretically based (socio-constructivism, social contextualisation, empowerment, action
planning) and reproducible, thanks to curricula and handouts for educators and learners. The subjects will be
recruited from five hospital outpatient settings all over Reunion Island. The main eligibility criteria include: age
≥18 years, type 2 diabetes treated for more than one year, HbA1c ≥ 7.5% for ≥3 months, without any severe
evolving complication (ischaemic or proliferative retinopathy, severe renal insufficiency, coronaropathy or evolving
foot lesion), and absence of any major physical or cognitive handicap. The primary outcome measure is HbA1c
evolution between inclusion and 2 years. The secondary outcome measures include anthropometric indicators,
blood pressure, lipids, antidiabetic medications, level of physical activity, food ingestion, quality of life, social
support, anxiety, depression levels and self-efficacy. An associated nested qualitative study will be conducted with
30 to 40 subjects in order to analyse the learning and adaptation processes during the education cycles, and
throughout the study.
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Conclusions: This research will help to address the necessary but difficult issue of structuring therapeutic education
in type 2 diabetes based on: efficacy and potential interest of organising on-going empowerment group–sessions,
at close quarters, over the long term, in a heterogeneous socioeconomic environment.
Trial registration: ID_RCB number: 2011-A00046-35
Clinicaltrials.gov number: NCT01425866
Keywords: Randomised controlled trial, Self-management education, Type 2 diabetes, Learning nests, Reunion
Island
Background
Type 2 diabetes (T2D) is a chronic and increasingly
common disease linked to changes associated with sed-
entary lifestyles and inappropriate food energy intake
[1]. The prevalence of known and treated diabetes is
close to 4% in France, and up to 18% among adults aged
over 30 years in Reunion Island, a French overseas re-
gion [2]. This situation gives rise to major costs, with
overall expenditure in France estimated at €5,710 billion
in 2000 [3]. In Reunion, the financial direct impact asso-
ciated with diabetes and its complications is estimated at
€5,451 per patient [4].
Intervention trials in T2D have clearly shown that
complications can be prevented or delayed by rigorous
control of the blood sugar level and risk factors [5,6]. An
improvement of one point in HbA1c is associated with a
20% decrease in the occurrence of macrovascular com-
plications and 30% to 40% decrease of microvascular
complications [6]. Diabetes and the associated risk fac-
tors nevertheless remain poorly controlled for the most
part [7,8]. In Reunion Island, as in France, glycaemic tar-
gets are not achieved: in the REDIA study, HbA1c was
8.4 ± 0.2% in patients treated with oral antidiabetic drugs
(OAD) and 9 ± 0.5% in insulin-treated patients [2].
For subjects with T2D, four imperatives must be main-
tained over the long term to contribute to the preven-
tion of complications: adherence to diet, physical
activity, treatments and monitoring checks. In order to
achieve these objectives the treatment, and optimum
medical follow-up, must be associated with therapeutic
patient education [9-11]. Self-management education
(SME) aims to help patients to acquire or maintain the
skills they need to manage their life with a chronic dis-
ease as effectively as possible [12]. These education
actions must be based on solid theoretical foundations
which take into account the complexity of the chronic
disease [13-16] and the integration of the individual
[15,17,18] in his or her social, family and cultural envir-
onment, as part of an appropriate approach taking into
account social configurations [19,20] and capacities for
change [21].
Several randomised trials assessing SME in T2D have
been carried out in the last 20 years. Reviews and meta-
analyses are available [22-25]. These have produced
overall positive effects of intensive initial therapeutic
education in T2D. However, results remain moderate be-
yond the short term (six months to 1 year). In known
T2D, five to 10 years on average after diagnosis,
improvements have been demonstrated in metabolic
control, self-efficacy, self-management practices, satisfac-
tion and quality of life [25], including in elderly subjects
and ethnic minorities [26]. The currently available data
underline the need to test structured and replicable
group approaches with long-term educational multidis-
ciplinary support, on precise theoretical bases and
adapted to different publics and cultures [22,27,28].
Interventions calling for group education have two
major attractions: reduced costs due to the grouping of
several patients with a trainer, and effective learning
time which enables patients to gain knowledge and to
develop new skills. Nevertheless, the practice of group
education could be difficult to implement, essentially be-
cause of organisational problems.
Whereas the effects of initial structured education
have by and large been demonstrated at one year, the
results remain moderate and appear to decrease there-
after. In a population of disadvantaged patients with
poorly controlled diabetes, Brown et al., [29] showed the
positive effects at one year of more numerous and
repeated group sessions. The total effective education
time improves the overall results of self-management
programmes up to one year [22,29-32], but total uncer-
tainty remains with regard to the question of providing
on-going support with group education beyond one year
for patients who received a structured initial education
cycle [23-25,33]. The four-year ROMEO Italian trial [32]
compared “systemic” group education with medical
follow-up alone. The sessions were conducted on an
outpatient basis within the diabetes secondary care
structure. They showed a very positive effect on the
metabolic control, increasing over time. The interven-
tion comprised one hour education sessions delivered on
a three monthly basis. The DESMOND programme, in-
cluding a single initial 6-hr structured education cycle of
six hours, in a recently diagnosed T2D, has had a
favourable impact on weight, risk factors, beliefs and
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health practices, but no effect on the level of HbA1c at
one and three years compared to a randomised control
group [34,35]. A self-management intervention involving
10 two-hour group sessions in a primary care setting in
Sweden, over a period of nine months, showed a 1.4%
difference in HbA1c level at five years [36]. The require-
ment for long term maintenance closer to patients, at
the community level and/or led by peer educators, has
been stressed [37,38]. The expert patient education (X-
PERT) programme delivered over six 2 hour-sessions
reported HbA1c improvements at 14 months (−0.6% v
0.1%), although long term outcomes have not yet been
reported [39].
In Reunion, the population remains socially and eco-
nomically fragile on the whole [40]. A very high propor-
tion −43.6% in 2002 – receive free complementary
health cover. The REDIA-prev2 study conducted in 2004
in the two hospital centres in the north and the south of
the island, failed to demonstrate the effect at one year of
quarterly one-to-one counselling encounter with a regis-
tered nurse educator and a dietician [31]. Since 2004,
the RéuCARE (Réunion Cœur Artères Rein Education)
regional network in Reunion is based around the estab-
lishment of group SMEs in accordance with the learning
nests approach whose theoretical bases draw on socio-
constructivism, empowerment and cognitive social the-
ories, and integrate the heterogeneity of individuals,
including literacy level heterogeneity [41]. The educa-
tional group sessions take place at close quarters, orga-
nised all over Reunion Island. Educators are health
professionals trained to hold learning sessions, with the
learning nests empowerment approach. The present
ERMIES study challenges the hypothesis that in
difficult-to-control T2D a feasible and reproducible
group-based structured empowering SME, lasting for
two years at the proximity level, helps to achieve better
metabolic control, as evidenced by the level of HbA1c,
compared to an initial education cycle only. The
ERMIES programme includes in both control and inter-
vention groups an initial cycle made up of a minimum
of three 2 hr long sessions in an empowerment model.
The programme in the intervention group involves sup-
plementary 4-monthly empowerment 2 hr sessions over
2 years.
Methods/Design
Trial design
This is a multicentre open (except during the common
initial education cycle) randomised two-arm controlled
trial (Figure 1). This trial will be associated with a quali-
tative ethno-sociological study conducted on a sample of
30–40 persons.
Patients will be recruited from five different outpatient
secondary settings in the four hospitals of the Reunion
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Figure 1 Design of the protocol over two years in Reunion Island, ERMIES, 2011–2014.
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Island, and will be seen in outpatient consultations.
Detailed information will be given by the investigating
physician on the objectives of the study, its nature and
constraints, the anticipated risks, and the expected bene-
fits. Patients will be included in the study, and followed-
up for two years, once a consent form has been signed.
Eligibility criteria
1. Inclusion criteria: patients aged over 18 with type 2
diabetes, defined in accordance with WHO criteria
treated for at least one year (OAD and/or insulin
and/or GLP-1 analog); HbA1c ≥ 7.5% for three
months or over; treatment regimen stable for at least
three months (except for possible changes to insulin
doses in the previous three months); living in
Reunion Island, affiliated to French national health
insurance, and patients having signed a consent form
for participation in the trial.
2. Non-inclusion criteria: current or scheduled
treatment liable to influence blood sugar levels, such
as corticotherapy; current or recent hospitalisation
(< three months) associated with the diabetes;
structured education intervention in hospital or on
outpatient basis in previous three months; severe
evolving current complication: ischemic or
proliferative retinopathy, severe chronic renal
insufficiency (clearance < 15 ml/min), coronary heart
disease, foot lesions; current pregnancy or desire for
pregnancy during the trial; evolving cancer (except
baso-cellular or spino-cellular cutaneous
epithelioma); severe physical, cognitive or mental
illness handicap; concomitant participation in a
therapeutic intervention trial.
Interventions
The patients randomised in both arms will benefit from
a structured initial cycle. Trained educators, blind to the
subsequent group allocation, will conduct this initial
group education cycle within the 12 weeks following in-
clusion. At the end of these 12 weeks the blinding will
be lifted, and the patients randomised in the two-year
education arm will continue to receive on-going struc-
tured group education. All group sessions will take place
at close quarters, organised by the RéuCARE health
network in specific locations in each town (municipal
and/or community settings).
Patients are reminded by telephone during the week
prior to each educational session to confirm the date,
time and place. Patients who fail to attend the session
will be called within two days and offered a new
schedule.
Structured group SME intervention
1. The theoretical basis and framework of the Learning
nests’ approach for the structured educational
intervention [14,42].
The complex nature of chronic diseases requires that
therapeutic education takes into account both its bio-
medical and psychosocial dimensions. Learning nests
work on knowledge to be built, and social, individual
and contextual dimensions of learning, as well as the
required decision of actions on a long-term basis, taking
into account the heterogeneity of individuals and of their
conditions. The learning nests are based on the contri-
butions of socio-constructivism [43,44], and empower-
ment [45], and take into account the enhancement of
self-efficacy [18], through skill mastery, problem solving,
decision making and action planning.
Fine components structure the approach of learning
nest group sessions:
– Component 1: Self analysis of relevant knowledge.
The learner is placed in a condition to be able to
analyse the relevant knowledge before making the
decisions, which will be his own and not
subordinated to those of the educator. Each learning
nest offers a constructive meeting between the
learners’ ideas and the reference knowledge. Since
the Learning nests do not include lectures, this
meeting is dealt with through diversified actions
exercised by the learner, on forms of knowledge that
are made manifest and manipulable.
– Component 2: Acknowledgement of individual
contexts and problem-solving. The patient’s
“ordinary” context is legitimised by virtue of the
visibility conferred on it (photographs, handouts,
material, foods, …). The learner can thus identify
the affordances of his or her environment. The
learner can continue to “manipulate” the reference
knowledge in his own particular context. The
encounter with the reference knowledge takes place
in the presence of the health professional, and this
body of knowledge is conveyed into the patients’
context in the form of booklets that make sense to
them, because the information has been put
together there and then.
– Component 3: Individual heterogeneity as an asset
for self-assessment and action. The heterogeneity of
the patients is not considered a problem, but as
something of value, which is taken into account in
the very act of designing the situation. The analytic
dimension of the work to be carried out by patients
is of importance. The specific individual
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characteristics of the patients can be integrated
without exception. The outcome of each learning
nest thus varies over a range of different solutions,
and not a single one.
– Component 4: The long lasting dimension of self
management. The learning nests integrate the
lasting dimension of chronic illness and the
necessity of thinking the action over for a long time
before seeing the first results. The decision for
action always remains the property of the patient,
with a space for encouraged actions in parallel,
which leads the trainer to work with the patient’s
individual dispositions, helping the patient to
become aware of the advantages and constraints of
his environment. At the end of each group session
patients identify a goal and an action plan related to
their context. At the beginning of the each
subsequent session patients are invited to reflect on
their experience of working on their self-selected
goals, and talk about what they had learned and how
it could be applied in the future. Patients are
encouraged to discuss events that had occurred and
to reflect on how these events had affected self-
management and action.
– Component 5: Culturally tailored education
materials. In addition to ensuring cultural relevance
by focusing on the priorities and the personal
contexts of the patients in the program, learning
nests use education materials that are developed
with and for the target audience: local foods,
contextual photographs, natural surroundings,
occupations, clothing, appropriate reading level,
coloured items (for identification).
Learning nests incorporate and emphasise behavioural
strategies, rather than a traditional didactic approach, in-
cluding curricula and handouts that have been devel-
oped to meet the specific needs of the target population
[14,19,40,46]. They also involve psychosocial dimensions,
and the presence of the context in which the chronic ill-
ness is dealt [47] with on a daily basis, and the patient’s
need for a decision on actions to be taken.
The learning nest can be defined as a learning empower-
ment situation centred on the construction of bodies of
knowledge, in which the knowledge worked on in a given
situation will enable the patient to take decisions relating
to his health management. The patient has the possibility
to modify his everyday practices (nutrition, physical activ-
ity, taking medication) while bearing in mind his/her exist-
ence in relation with the others, with his environment, his
resources and his culture. Patients become aware of the
issues they can manage on a priority basis, taking account
of not only of medical dimensions (level of HbA1c, other
risk factors, treatment, etc.), but also psycho-sociological,
contextual, environmental, cultural and economic dimen-
sions. This work results in a decision which incorporates a
positive view of health and feasibility in contexts in which
the patient will develop. Whatever the specific cultural, re-
ligious and socio-economic background of the patients,
each can work on the basis of his own data, reinforce his
own views and find a way ahead which takes into account
the constraints and strengths of his social, family and per-
sonal life.
The material, process and the design of each educa-
tional group session are detailed in specific booklets
for learners, including those with literacy difficulties.
Booklets for educators include a curriculum written
protocol, available in French and in the English language
(EPMC booklets; Education Prévention des Maladies
Chroniques [48]), allowing replication of the educational
intervention.
2. Initial education cycle
The initial cycle consists of 3 to 7 educational weekly
or bi-weekly 2-hour group sessions for 4 to 10 patients:
– Personalised assessment group session (120 minutes):
patients work on their own clinical and biological
factors that can influence health maintenance (blood
glucose, blood pressure, lipids, weight, waist
circumference, smoking), before looking at lifestyle
measure effects and specific impacts of eventual
changes. They then scrutinise the feasibility of action
planning and implementation in real life, and goal-
setting taking into account all individual, social, and
contextual dimensions. At the end of this session,
each learner can schedule 2 to 6 specific additional
focused sessions, according his/her needs and goal-
setting.
– Two to 6 specific additional focused sessions of 90
to 120 minutes, spaced at intervals of 1 to 2 weeks
(3 weeks maximum). These sessions are selected on
the six following themes: self-monitoring and
adaptation of treatment - physical activity - food and
control of fat intake – understanding of diabetes and
treatment – challenges of insulin therapy –
prevention of foot lesions.
3. On-going SME support: personalised empowerment
follow-up including group sessions of 90 to 120
minutes each, with three to ten patients at 16, 32, 48,
64, 80 and 96 weeks. Each session will be scheduled
at the end of the previous session. Patients will work
on the progress of their indicators as follows: medical
(HbA1c levels, blood sugar, arterial pressure, lipids,
waist circumference, smoking, treatments); health
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coping and goal setting (action(s) initially decided on,
actual implementation, obstacles); cognitive (review
of knowledge gained through the first session
assessment session and additional sessions). The
summary of the session comprises objectives for
action(s) to be implemented and the scheduling of
optional additional sessions to support practical
implementation.
4. Educators
The professionals carrying out the sessions have been
specifically trained (long-term training by the
University Diploma on SME in chronic diseases, or
training with experience and skills validated in the
network). Training of educators include sessions on
biomedical knowledge on diabetes, nutrition and
treatment, educational skills, behavioural strategies,
learning nest and empowerment approach. In order
to “embrace empowerment”, health care
professionals have to make a paradigm shift from the
traditional approach to care and acknowledge that
patient are in control of their daily diabetes care,
making autonomous and informed decisions about
their diabetes self-management [49]. Additionally,
training includes for each thematic group sessions a
thorough review of the process, content, educator
role, learners actions, learning indicators, specificity
of goal setting and problem solving taking into
account individual, social and cultural context.
Control arm: group-based initial structured education
cycle only
In the control arm, patients receive only the initial struc-
tured education programme, conducted in the 12-week
period following inclusion.
Concomitant treatments and procedures
In both arms, patients will continue to receive quarterly
outpatient medical follow-up. Regular examinations and
therapeutic adaptation will take place in accordance with
the recommendations. The individual nursing or diet-
ician encounters, required in addition to the medical
appointments due to the evolution of the disease or
therapeutic changes (such as starting insulin, GLP-1
analogue) will be authorised whatever the arm.
Outcomes
The main outcome is the evolution of HbA1c (%) at two
years. The HbA1c will be measured by the HPLC
method in a centralised laboratory (biochemistry labora-
tory of the Félix Guyon hospital in St Denis).
The secondary outcomes will be as follows: quarterly
evolution of HbA1c (%), fasting blood glucose, an-
thropometric indicators (body mass index, waist circum-
ference), blood pressure, tobacco consumption, annual
screening of lipids (total cholesterol, triglycerides, HDL
and LDL cholesterol), antidiabetic treatments (type and
dose) and the occurrence or worsening of diabetic
complications. Health practices (level of physical activity
and food consumption) will be assessed by means of an-
nual questionnaires. These have been used in Reunion
Island for a number of descriptive or intervention stud-
ies: RECONSAL [50], REDIA-prev1 [51] and REDIA-
prev2 [31]:
– Physical activity: physical activity scores will be
assessed by means of a questionnaire developed on
the basis of the Baecke self-questionnaire [52],
which explores professional, sporting and leisure
exercise. Questions on domestic activity were added
to our studies.
– Food consumption: food consumption (reported
energy intake, macronutrient intake, dietary habits)
will be assessed by means of a rapid food frequency
questionnaire relating to weekly consumption [53].
Quantities of various foods are assessed by means of
a photo album. The validity of the questionnaire and
the photo album for the population of Reunion was
checked by comparison with food surveys.
The care and treatment courses will be assessed by
means of questionnaires at inclusion and at two years,
based on the questionnaire used in the French ENTRED
study [54] adapted to the situation and context in
Reunion and comprising 30 items.
Quality of life will be assessed annually by means of
the Diabetes Quality of Life, Brief Clinical Inventory
[55]. This scale, including 15 items and translated
into French for Reunion, was validated for this trial
among a sample of 150 Reunion’s patients presenting
diabetes.
Self-efficacy, social support and anxio-depressive state
will be assessed by means of psychometric scales vali-
dated for the purpose of the trial in Reunion. The feeling
of self-efficacy will be measured by means of section 3 of
the MDQ (Multidimensional Diabetes Questionnaire)
[56]. This questionnaire includes 13 items: seven for
self-efficacy and six for outcome expectations. The
patent’s perception of the specific social support from
the partner with regard to the treatment of the diabetes
will be assessed on the basis of 12 items derived from
the MDQ. The patient’s anxiety will be assessed by the
HADS (Hospital Anxiety and Depression Scale) [57].
The HADS includes seven items and is widely used and
validated in outpatient prospective studies. The depres-
sion level will be measured by means of the CES-D
[58,59], which comprises 20 items. The French versions
of the two latter tools have demonstrated their psycho-
metric qualities.
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The food consumption questionnaire will be con-
ducted face to face with the centre nurse trained for this
purpose before the start of the research. The other ques-
tionnaires will be self-administered, with the assistance
of the study nurse if necessary for subjects with low lit-
eracy levels.
Sample size consideration
The efficacy assessment is based on the following main
judgement criterion: developments between inclusion
(week 0) and two years (week 96) of the percentage of
glycated haemoglobin HbA1c (%).
The expected benefit is a decrease at two years of at
least 1% in the average HbA1c between the group
“structured on-going SME support” and the control
group “Initial structured education cycle only”. An abso-
lute difference of 1% at two years between the two
groups appears relevant [23,24,29,32,39,60-62].
To show an absolute difference of 1% of HbA1c, with
a standard deviation of 2.5%, a type I error rate of 5%
and a power of 80%, it is necessary to include 99 sub-
jects per group in a bilateral situation.
Because of an estimated data deficiency of 20% at two
years (drop out, refusals, deaths), it is planned to include
120 subjects per group, making a total of 240.
Randomisation methods
Block randomisation is carried out on two stratification
factors: insulin treatment on inclusion (yes/no - two
strata), and inclusion centre (five strata). The numbers
of participants in each group are balanced with a ratio of
1:1. The 10 randomisation lists are drawn up by the sta-
tistician of the CIC-EC of Reunion before the start of
the research.
Blinding
For all patients, the first phase (group-based initial edu-
cation cycle) will be conducted blind with regard to the
randomisation arm for patients, until 12 weeks at the
latest, researchers and education team. At the end of this
first phase the follow-up will therefore be unblinded.
Statistical methods
The statistical analyses will be carried out at the CIC-EC
in Reunion, under SASW (version 9.2, SAS Institute Inc.,
Cary, NC, USA).
Description of the initial characteristics of the
screened patients and of the included patients will be
done by usual statistics (number, percentage, average ±
standard deviation or median and range).
Effective implementation of the SME program and the
effective participation will be documented.
The assessment of efficacy of the intervention will be
performed in a single analysis, according to the intention
to treat principles (i.e. according to group allocated by
randomisation) with type I error equal 5%, and bilateral
formulation of Student t-test (primary analysis).
In the two compared groups, the deficient data on
HbA1c (%) at two years (week 96) will be replaced by
the measurement obtained at week 84.
If the primary analysis shows a significant difference
between the two groups, a comparison of the mean
change in HbA1c (%) S96-S0 will be done by the level of
participation (secondary analysis using 1-factor ANOVA
model): i) basic level ("initial structured therapeutic edu-
cation only"), ii) level 1 (“structured on-going SME sup-
port” without specific additional focused sessions), iii)
level 2 (“structured on-going SME support” with specific
additional focused sessions).
Analysis of longitudinal data gathered during two years
will used in generalised estimating equations (GEE)
adapted to repeated measurements in order to test the
trends described over the duration of the supervision.
Analysis of the time between randomisation and oc-
currence of a level of HbA1c <7% (first event observed)
will be performed by the Kaplan-Meier method, with
comparison of survival curves between groups by Log-
rank test.
At each annual collection point the anti-diabetic treat-
ments will be classified into four hierarchical categories:
1) non-insulin antidiabetic monotherapy, 2) non-insulin
antidiabetic bi-, tri- (or more) therapy, 3) one injection
of insulin, 4) two or more injections of insulin. Between
two collection points, moves from one category to a
higher (or lower) category will be identified as a
reinforcement (or reduction) of the treatment. The inter-
action between the intervention and treatment category
will be tested in the appropriate multivariate models
(ANCOVA, GEE, time-dependent variable in the Cox
model).
Nested qualitative study
The associated qualitative study will be conducted on a
sample of 30 to 40 persons in both arms, and will in-
clude observation and recording group sessions as well
as semi-directive conducted interviews at home.
The objectives of the ethno-sociological qualitative
study are: i) to analyse the learning processes during the
education sessions, and then in individual contexts to
analyse the developments in health ‘literacy’ is taken to
mean not only reading and writing ability and numeracy,
but also information searching, cognitive work and
decision-making [63] in the various areas covered by the
SME process. These areas are: food, physical activity,
control of risk factors in complications, blood sugar self-
monitoring and adaptation of the treatment. 2) analysing
the adaptation processes in context and their links with
the sessions, interactions in the education session and
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literacy levels; 3) endeavouring to generate barriers and
enablers in developing self-management.
The participants in the qualitative study will be
selected on a non-random basis by the head of the
ethno-sociological survey (M. Balcou-Debussche), so as
to have a sufficiently wide panel of participants, taking
account of the age, sex, length of time since the onset of
diabetes and its level of control and complications, pro-
fessional activity, habitat, socio-economic level and level
of education. The possibility of inclusion in the ethno-
sociological research (including interviews at home) will
be specified in the information letter and consent form.
Additional oral information will be provided for a quali-
tative study of participants on the aims and precise con-
ditions of this survey.
An analysis will be made of the content of the themes
covered in the interviews and the recurring themes. The
categories and signifiers will be developed using the con-
stant comparison method. The emerging themes can be
included and developed in new analysis and data-
gathering cycles [64]. The session observations will in-
clude an ethnographic summary of language interac-
tions, speaking and activities of participants. All the
data, themes and recurrence will be the subject of cross-
analyses of the same individuals according to the con-
text, sessions or interviews. The analyses will also cover
the evolution since the beginning of the research, as well
as differences between individuals. All the data will be
coded and analysed with the aid of the N-Vivo 9 soft-
ware QSR international.
Collection of biological samples
Serum collection will be performed at inclusion, as well as
at one year and two years for the purpose of a posteriori
secondary analyses on the evolution of more specific indi-
cators of the risk of long-term complications of type 2 dia-
betes. In particular, inflammation and immunity factors,
oxidative status and lipid fractions (size and density of
LDL, HDL fractions, atherogenic lipoproteins).
Ethics committee
This study has received approval from the ethics com-
mittee, “CPP Sud-ouest et Outre Mer III” and authorisa-
tion from the French Health Products Safety Agency
(Agence française de sécurité sanitaire des produits de
santé, Afssaps).
Discussion
Available studies which were carried out on the basis of
these inclusion criteria (adult diabetes patients
remaining at very high risk of complications due to per-
sistent poor blood glucose control with HbA1c in excess
of 7.5%) have shown a favourable effect from educational
intervention at six months and one year, but the
question of the efficacy of maintenance at two years, and
of intensification by means of on-going structured inter-
vention at the proximity level, still remains unanswered
as compared to a sole initial structured education.
The relatively heterogeneousness of these patients
showing insufficient therapeutic control (treatment by
OADs or GLP-1 analogue, basal or multi-day insulin
therapy) may give rise to significant differences in meta-
bolic control. Randomisation with stratification into two
groups in accordance with the addition of insulin ther-
apy will make it possible to balance the spread of treat-
ments between the two arms at the time of inclusion,
and to assess situations presenting comparable initial
medication treatments. On the other hand, anti-diabetic
treatments may mask the effects of therapeutic educa-
tion on the level of blood glucose control: i.e. the drug
therapy reinforcement required due to the lower efficacy
of the education in one group could minimise the differ-
ence between the two intervention groups. Although
that is not the case in the available studies that have
assessed this issue, it appears important to record the
changes of anti-diabetic treatments occurring through-
out the study [22,23,39].
Maintained structured educational on-going support
over two years requires co-ordination, in parallel with
medical and diabetological supervision, thanks to the ex-
istence of an education coordination network in Re-
union. The network has the resources and already
conducts structured education cycles. Self management
education sessions are carried out by trained and experi-
enced health care professionals, with an empowerment
approach. The SME style is theoretically based and re-
producible, with curricula and handouts making it pos-
sible to renew educational actions on the same bases.
The potential investment of peer educators or expert
patients has not been retained for this ERMIES study de-
sign, since the French and Reunion context is currently
not yet ready to include such issues. However, this is an
important clue to evaluate and implement in the future
[37-39].
The primary outcome will be based on the evolution
of HbA1c at two years, in order to measure the mainten-
ance of improved metabolic control by means of a reli-
able and representative gauge of the long-term risk of
microvascular and macrovascular complications. The
purpose of educational intervention on an individual
and on a collective level is to prevent the occurrence of
secondary complications in the long term. Demonstrat-
ing a significant effect on the prevention of secondary
complications will nevertheless take several years [5,6],
but HbA1c and cardiovascular risk factors are solid
intermediate outcomes in the case of type 2 diabetes.
Since it appears difficult to envisage a combined out-
come of the various cardiovascular risk factors with
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HbA1c, we have chosen to retain HbA1c as the main
outcome, particularly since most of the available studies
have been based on it.
The qualitative, ethno-sociological study [14] will allow a
more detailed analysis of the determinants and processes
enabling people to make progress in the control of the dis-
ease, taking into account the interactions during the
session, but also particular contexts, (individual, social, cul-
tural factors) [65], and potential strengths to be leveraged
for improved health literacy, which is deemed to mean the
integration of significant processes to acquire information
and knowledge, understanding and decisions [63].
The efficacy and potential significance of organising
education groups at close quarters over the long term
are important to specify. Delivering to each patient an
individualised multidisciplinary therapeutic education
requires time and human resources, and entails a signifi-
cant cost. On the other hand self-management group
education is difficult to structure, and requires organisa-
tional capacities of teams and professionals, but it ultim-
ately enables the individual approach to be reserved for
cases that genuinely need it. Furthermore, the modalities
of patient-adapted group education are still being
debated. The results of the present study will thus indi-
cate whether such long-term structuring patient educa-
tion in insufficiently controlled diabetes provides a real
benefit, as compared to initial education over several
weeks. The possibility, within the fabric of the current
healthcare system, particularly in France and Reunion, of
offering structured, community-based education to
patients in difficulty opens up the potential to provide
support for specialist and hospital teams which are fa-
cing increasing demand for type 2 diabetes management.
The link to a qualitative ethno-sociological study will
provide knowledge of the learning processes in context,
and change factors in practices, which will make it pos-
sible to adapt and direct future actions in terms of pre-
vention and therapeutic education.
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